The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostaglandin E2-Global Market Insights and Sales Trends 2025
Synopsis
Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
The global Prostaglandin E2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Prostaglandin E2 in various end use industries. The expanding demands from the Cancer Treatment, Neurological Treatment, Endocrinological Treatment and Others, are propelling Prostaglandin E2 market. Low Purity(Below 97%), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity(Above 97% and Below 99%) segment is estimated at % CAGR for the next seven-year period.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostaglandin E2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostaglandin E2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostaglandin E2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostaglandin E2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostaglandin E2 covered in this report include R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, AbMole Bioscience and Bio-Techne, etc.
The global Prostaglandin E2 market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Global Prostaglandin E2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostaglandin E2 market, Segment by Type:
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Global Prostaglandin E2 market, by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostaglandin E2 companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
The global Prostaglandin E2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Prostaglandin E2 in various end use industries. The expanding demands from the Cancer Treatment, Neurological Treatment, Endocrinological Treatment and Others, are propelling Prostaglandin E2 market. Low Purity(Below 97%), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity(Above 97% and Below 99%) segment is estimated at % CAGR for the next seven-year period.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostaglandin E2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostaglandin E2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostaglandin E2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostaglandin E2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostaglandin E2 covered in this report include R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, AbMole Bioscience and Bio-Techne, etc.
The global Prostaglandin E2 market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Global Prostaglandin E2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostaglandin E2 market, Segment by Type:
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Global Prostaglandin E2 market, by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostaglandin E2 companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prostaglandin E2
1.1 Prostaglandin E2 Market Overview
1.1.1 Prostaglandin E2 Product Scope
1.1.2 Prostaglandin E2 Market Status and Outlook
1.2 Global Prostaglandin E2 Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prostaglandin E2 Market Size by Region (2018-2029)
1.4 Global Prostaglandin E2 Historic Market Size by Region (2018-2023)
1.5 Global Prostaglandin E2 Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prostaglandin E2 Market Size (2018-2029)
1.6.1 North America Prostaglandin E2 Market Size (2018-2029)
1.6.2 Europe Prostaglandin E2 Market Size (2018-2029)
1.6.3 Asia-Pacific Prostaglandin E2 Market Size (2018-2029)
1.6.4 Latin America Prostaglandin E2 Market Size (2018-2029)
1.6.5 Middle East & Africa Prostaglandin E2 Market Size (2018-2029)
2 Prostaglandin E2 Market by Type
2.1 Introduction
2.1.1 Low Purity(Below 97%)
2.1.2 Purity(Above 97% and Below 99%)
2.1.3 High Purity(Above 99%)
2.1.4 Others
2.2 Global Prostaglandin E2 Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prostaglandin E2 Historic Market Size by Type (2018-2023)
2.2.2 Global Prostaglandin E2 Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostaglandin E2 Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prostaglandin E2 Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prostaglandin E2 Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prostaglandin E2 Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prostaglandin E2 Revenue Breakdown by Type (2018-2029)
3 Prostaglandin E2 Market Overview by Application
3.1 Introduction
3.1.1 Cancer Treatment
3.1.2 Neurological Treatment
3.1.3 Endocrinological Treatment
3.1.4 Others
3.2 Global Prostaglandin E2 Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prostaglandin E2 Historic Market Size by Application (2018-2023)
3.2.2 Global Prostaglandin E2 Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostaglandin E2 Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prostaglandin E2 Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prostaglandin E2 Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prostaglandin E2 Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prostaglandin E2 Revenue Breakdown by Application (2018-2029)
4 Prostaglandin E2 Competition Analysis by Players
4.1 Global Prostaglandin E2 Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostaglandin E2 as of 2022)
4.3 Date of Key Players Enter into Prostaglandin E2 Market
4.4 Global Top Players Prostaglandin E2 Headquarters and Area Served
4.5 Key Players Prostaglandin E2 Product Solution and Service
4.6 Competitive Status
4.6.1 Prostaglandin E2 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 R&D Systems
5.1.1 R&D Systems Profile
5.1.2 R&D Systems Main Business
5.1.3 R&D Systems Prostaglandin E2 Products, Services and Solutions
5.1.4 R&D Systems Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.1.5 R&D Systems Recent Developments
5.2 Abcam
5.2.1 Abcam Profile
5.2.2 Abcam Main Business
5.2.3 Abcam Prostaglandin E2 Products, Services and Solutions
5.2.4 Abcam Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.2.5 Abcam Recent Developments
5.3 Stemgent
5.3.1 Stemgent Profile
5.3.2 Stemgent Main Business
5.3.3 Stemgent Prostaglandin E2 Products, Services and Solutions
5.3.4 Stemgent Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.3.5 Cayman Chemical Recent Developments
5.4 Cayman Chemical
5.4.1 Cayman Chemical Profile
5.4.2 Cayman Chemical Main Business
5.4.3 Cayman Chemical Prostaglandin E2 Products, Services and Solutions
5.4.4 Cayman Chemical Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.4.5 Cayman Chemical Recent Developments
5.5 Santa Cruz Biotechnology
5.5.1 Santa Cruz Biotechnology Profile
5.5.2 Santa Cruz Biotechnology Main Business
5.5.3 Santa Cruz Biotechnology Prostaglandin E2 Products, Services and Solutions
5.5.4 Santa Cruz Biotechnology Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.5.5 Santa Cruz Biotechnology Recent Developments
5.6 STEMCELL Technologies
5.6.1 STEMCELL Technologies Profile
5.6.2 STEMCELL Technologies Main Business
5.6.3 STEMCELL Technologies Prostaglandin E2 Products, Services and Solutions
5.6.4 STEMCELL Technologies Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.6.5 STEMCELL Technologies Recent Developments
5.7 AbMole Bioscience
5.7.1 AbMole Bioscience Profile
5.7.2 AbMole Bioscience Main Business
5.7.3 AbMole Bioscience Prostaglandin E2 Products, Services and Solutions
5.7.4 AbMole Bioscience Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.7.5 AbMole Bioscience Recent Developments
5.8 Bio-Techne
5.8.1 Bio-Techne Profile
5.8.2 Bio-Techne Main Business
5.8.3 Bio-Techne Prostaglandin E2 Products, Services and Solutions
5.8.4 Bio-Techne Prostaglandin E2 Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Techne Recent Developments
6 North America
6.1 North America Prostaglandin E2 Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostaglandin E2 Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostaglandin E2 Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostaglandin E2 Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostaglandin E2 Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostaglandin E2 Market Dynamics
11.1 Prostaglandin E2 Industry Trends
11.2 Prostaglandin E2 Market Drivers
11.3 Prostaglandin E2 Market Challenges
11.4 Prostaglandin E2 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
